FDA Approves New Treatments for Colorectal Cancer, Leukemia, and Melanoma
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Category: Featured
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer...
The American Association for Cancer Research (AACR) publishes eight esteemed scientific journals. Each month, these journals feature a wide...
Last week, the U.S. Food and Drug Administration (FDA) increased the number of types of cancer for which pembrolizumab...
For many aspiring investigators, pursuing a career in cancer research can be a complex exploration of self and purpose. In...
“We are in a promising time for cancer research and treatment; however, ovarian cancer remains difficult to treat, since...
Assessing new anticancer therapeutics in clinical trials is a vital step in evaluating the toxicity and efficacy of treatment...
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
While immunotherapy may be the latest tool in the treatment armamentarium for cancer, many ongoing clinical trials are assessing...